Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity Cédric MénardFrançois MartinFrançois Ghiringhelli Review 28 March 2008 Pages: 1579 - 1587
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration A. C. Inge BoullartErik H. J. G. AarntzenI. Jolanda M. de Vries Original Article Open access 06 March 2008 Pages: 1589 - 1597
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma Jaafar BennounaEmmanuelle BompasSylvie Négrier Original Article 27 February 2008 Pages: 1599 - 1609
Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP–PKA signaling and immunosuppression Yunyun SuXiaojun HuangElieser Gorelik Original Article 08 March 2008 Pages: 1611 - 1623
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen Michela CroceRaffaella MeazzaSilvano Ferrini Original Article 07 March 2008 Pages: 1625 - 1634
Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer Benjamin B. WilliamsMeg WallRobert G. Ramsay Original Article 03 April 2008 Pages: 1635 - 1645
Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling Hirobumi AsaiHiroko IijimaKoutaro Maeda Original Article 15 March 2008 Pages: 1647 - 1655
Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses Jian-Qing GaoNaoko KanagawaShinsaku Nakagawa Original Article 08 March 2008 Pages: 1657 - 1664
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells Patrizia StoitznerLaura K. GreenFranca Ronchese Original Article 01 March 2008 Pages: 1665 - 1673
Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells Patrizia StoitznerLaura K. GreenFranca Ronchese Erratum 05 June 2008 Pages: 1675 - 1675
Progress in Vaccination against Cancer 2007 (PIVAC 7) Symposium Paper 26 August 2008 Pages: 1677 - 1677
A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity Jay A. BerzofskyMasaki Terabe Symposium Paper 28 March 2008 Pages: 1679 - 1683
Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike? Raffaele Adolfo CalogeroElena QuaglinoFederica Cavallo Symposium Paper 20 February 2008 Pages: 1685 - 1694
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumors Hyun-Il ChoGuilian NiuEsteban Celis Symposium Paper 06 February 2008 Pages: 1695 - 1703
Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia M. PalmaL. AdamsonA. Choudhury Symposium Paper 29 July 2008 Pages: 1705 - 1710
The “A, B and C” of Her-2 DNA vaccine development Wei-Zen WeiJennifer JacobYi-chi M. Kong Symposium Paper 14 February 2008 Pages: 1711 - 1717
Molecular mechanisms of MHC class I abnormalities and APM components in human tumors Barbara Seliger Symposium Paper 12 April 2008 Pages: 1719 - 1726
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations Natalia AptsiauriRafael CarreteroFederico Garrido Symposium Paper 20 May 2008 Pages: 1727 - 1733
Cancer treatment: the combination of vaccination with other therapies Mads Hald AndersenRikke Bæk SørensenPer thor Straten Symposium Paper Open access 20 February 2008 Pages: 1735 - 1743